Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Dapas

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Pharmaceutics|April 28, 2023
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic ApproachesTanja Jesenko, Simona Kranjc Brezar, Maja Cemazar, et al.
Expert Opinion on Drug Delivery|March 8, 2017
Strategies to optimize siRNA delivery to hepatocellular carcinoma cellsLucia Scarabel, Francesca Perrone, Marica Garziera, et al.
Molecules (Basel, Switzerland)|March 31, 2018
Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and EffectivenessRossella Farra, Francesco Musiani, Francesca Perrone, et al.
Cancers|April 12, 2022
5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 PathwayFederica Tonon, Maja Cemazar, Urska Kamensek, et al.
Cancers|March 28, 2026
Correction: Tonon et al. 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway. <i>Cancers</i> 2022, <i>14</i>, 1630Federica Tonon, Maja Cemazar, Urska Kamensek, et al.
Pharmaceutics|May 25, 2024
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer CellsMarianna Maddaloni, Rossella Farra, Barbara Dapas, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Pharmaceutics|April 28, 2023
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic ApproachesTanja Jesenko, Simona Kranjc Brezar, Maja Cemazar, et al.
Expert Opinion on Drug Delivery|March 8, 2017
Strategies to optimize siRNA delivery to hepatocellular carcinoma cellsLucia Scarabel, Francesca Perrone, Marica Garziera, et al.
Molecules (Basel, Switzerland)|March 31, 2018
Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and EffectivenessRossella Farra, Francesco Musiani, Francesca Perrone, et al.
Cancers|April 12, 2022
5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 PathwayFederica Tonon, Maja Cemazar, Urska Kamensek, et al.
Cancers|March 28, 2026
Correction: Tonon et al. 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway. <i>Cancers</i> 2022, <i>14</i>, 1630Federica Tonon, Maja Cemazar, Urska Kamensek, et al.
Pharmaceutics|May 25, 2024
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer CellsMarianna Maddaloni, Rossella Farra, Barbara Dapas, et al.
Pageof 6